Physician profile
Vicky S Fischer
NPI 1174787410
$1,797.09
in general payments reported to CMS, 2019-2025
16 companies · $669 in 2025
The $669 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $176 · 2021: $165 · 2022: $66.03 · 2023: $469 · 2024: $138 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213 · Entertainment: $62.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.36 |
| Entertainment | $62.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $368.67 | 2020-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $224.11 | 2023-2025 | Infuse |
| Glaukos Corporation | $203.45 | 2025 | Photrexa Viscous and Photrexa |
| Johnson & Johnson Vision Care, INC. | $143.04 | 2023-2025 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $135.51 | 2023 | Lipiflow System Activator (Disposable) |
| Dompe US, INC. | $121.82 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $118.43 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $97.22 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $87.19 | 2021 | |
| Visioneering Technologies, INC. | $81.54 | 2019 | |
| Optos, INC. | $62.32 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.35 | 2019-2020 | |
| Rxsight INC | $44.09 | 2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Abbvie INC. | $22.20 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $14.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicky Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.